For immediate release: March 14, 2005
VANCOUVER – Inex Pharmaceuticals Corporation ("INEX"; TSX: IEX) announced today that it will hold a conference call and webcast on Thursday, March 17, 2005 at 9:00 a.m. PST (12:00 noon EST) to discuss 2004 year end operating results and to provide an update on developments at the Company.
To participate in the conference call, please dial 416-405-9328 or 1-800-387-6216. The call will be available for replay until March 24, 2005 by calling 416-695-5800 or 1-800-408-3053 and entering the pass code 3141343#.
The live or archived webcast can be accessed through the Company’s website at www.inexpharm.com.
About INEX
INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer.
INEX investor contact:
Ian Mortimer
Vice President, Finance and Chief Financial Officer
Phone: 604-419-3200
Email: info@inexpharm.com
Website: www.inexpharm.com
INEX media contact:
Karen Cook Boas
James Hoggan & Associates Inc.
Phone: 604-739-7500
Email: kcook@hoggan.com
INEX’s common shares are traded on the Toronto Stock Exchange under the trading symbol “IEX”.
